018680815

ALTIBODIES

---

March 31, 2022

Trademark Summary

The trademark application ALTIBODIES was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 19, 2022, and it was registered by office on July 27, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on August 14, 2022.

---

Goods And Services

• The mark was filed in class 42 with Genetic engineering services, namely, the production of genetically-engineered antibodies for others.